Remdesivir to enter Phase III clinical trials; Advanced tracking capabilities, the key to reopening; Latam countries that extended quarantines and those loosening restrictions: The Albright Stonebridge Group global update

Go beyond the numbers on contagion and lethality of COVID-19. Get detailed regional analysis on the progression of the pandemic, and on government’s responses, prepared by the global strategic advisory and commercial diplomacy firm, Albright Stonebridge Group. Key Takeaways Gilead Sciences is pursuing Phase III clinical trials in the U.S., Asia, and Europe for their therapeutic drug Remdesivir, which is thought to be effective in helping COVID-19 patients recover more quickly. Companies like Moderna and China’s CanSino continue to move forward with plans for Phase II clinical trials. Pressure is mounting across the world for governments to resume economic activity. In most instances, reopening is coupled with more advanced COVID-19 tracing capabilities. Countries like South Korea and Singapore have been […]

This site uses Akismet to reduce spam. Learn how your comment data is processed.


Barbados, a groundbreaker in international agenda proposals and energy transition goals

Prime Minister Mia Mottley is behind the recent rise...

The roadmap for new policy-making: a conversation with the Executive Secretary of ECLAC. 

Although unthinkable, the pandemic brought something good. “It moved...

Products and sustainability: The plans of Coca-Cola’s President of Latin America

This year, Coca-Cola introduced to Latin America a beverage...